Biofarm Sa · BVB:BIO
Biofarm Sa — 9M 2020 Earnings Presentation
19 slides from Biofarm Sa's earnings presentation, November 2020
Slide 1: Biofarm cover
Health and well-being are linked. Our concern is to o only those products that i our innovation, performance ar of experience. @ BIOFARM
Slide 2: Individual financial statements 30.09.2020
Individual financial statements 30.09.2020 This individual financial statements for the period January – September 2020 is made by BIOFARM S.A. (“BIOFARM”) and aims to present the financial results of BIOFARM to the investors (shareholders, creditors, analysts, financial press), thus having a purely
Slide 3: Company Profile
COMPANY PROFILE Biofarm is a Romanian company built on expertise, innovation and performance. Values we trust • Top 5 manufacturer of medicines on the highly competitive Romanian market. • The most important Romanian manufacturer of soft gelatine capsules. About Us Responsibility • Top 3 Romanian pr
Slide 4: History and Milestones
HISTORY AND MILESTONES Biofarm is one of the most important manufactures in Romania with almost 100 years history of expertise and performance. Year of Trading on the Production lines Year of ISO and expansion stock exchange certification OHSAS certification Biofarm opens the first All production li
Slide 5: Biofarm Worldwide
BIOFARM WORLDWIDE Biofarm operates in Romania and exports to 12 other countries. CORE MARKET - ROMANIA EXPORT MARKETS External markets long-term strategy includes:
Slide 6: Biofarm Brands
BIOFARM BRANDS Biofarm portfolio consists of over 200 products that covers over 60 therapeutic areas 3 CORE CATEGORIES core core core Digestive & Metabolic Respiratory & ENT Cardiovascular & Circulatory
Slide 7: Executive Summary 30.09.2020
Executive Summary 30.09.2020 +12% 157 Turnover for Q3 2020 (no impact IFRS 15) is with 140 12% higher than 2019 Total expenses are with 13% higher than 2019 101 90 Operationg profit is ca. RON 54.7 Mil. increasing with 11% than Q3 2019 55 49 Net profit is RON 45.5 Mil. increasing with ca. 13
Slide 8: Agenda
Agenda Global Result Statement Financial Position Statement Financial Indicators & Cash Flows
Slide 9: Global Result Statement on 30.09.2020
Global Result Statement on 30.09.2020 - RON- Revenue Revenue Revenue Revenue Income and expenses statement 30-Sept -2020 30-Sept-2019 2020/ 2019 2020/ 2019 Income from sales 156.923.978 140.143.660 16.780.318 12% IFRS 15 adjustment income -3.132.342 -4.627.703 Other operating income 168.192 632.251
Slide 10: Global Result Statement
Global Result Statement Revenue Revenue Sales income 30-Sep-20 30-Sep-19 2020/ 2019 2020/ 2019 Sales of finished products 191.844.976 166.783.967 25.061.009 15% Sales of merchandise 751.841 1.703.546 (951.705) -56% ▪ The income (no impact IFRS15) increase with IFRS 15 adjustment income (3.132.342) (
Slide 11: Global Result Statement
Global Result Statement Other Operating Expenses 30-Sep-20 30-Sep-19 Revenue Revenue 2020/ 2019 2020/ 2019 ▪ Biofarm is the most important Romanian manufacturer Utilitati Rents 3.154.254 1.121.716 3.455.401 999.215 (301.147) 122.501 -9% 12% of softgel capsules, between the first 3 Romanian Chirie -
Slide 12: Agenda
Agenda Global Result Statement Financial Position Statement Financial Indicators & Cash Flows
Slide 13: Financial Position Statement
Financial Position Statement Revenue Revenue Assets 30-Sep-2020 31-Dec-2019 2020/ 2019 2020/ 2019 Tangible assets 132.502.118 126.454.307 6.047.810 5% Real estate assets 11.533.330 11.533.330 - 0% Intangible assets 547.190 839.771 (292.581) -35% Other fixed assets 9.095 7.095 2.000 28% Deferred tax
Slide 14: Financial Position Statement
Financial Position Statement Revenue Revenue TANGIBLE ASSETS 30-Sep-2020 31-Dec-2019 2020/ 2019 2020/ 2019 Lands and constructions 57.047.705 55.517.011 1.530.694 3% Technical installations and machines 37.747.144 39.087.509 (1.340.365) -3% Other installations, machinery and furniture 300.521 262.76
Slide 15: Financial Position Statement
Financial Position Statement Realizat Realizat Cash and cash equivalents 30-Sep-2020 31-Dec-2019 2020/ 2020/ 2019 2019 ▪ Cash decreased compared to the end of 2019 due to Cash in bank 39.091.061 12.249.251 26.841.810 219% Cash and cash equivalents 9.881 4.769 5.112 107% dividend payments amounting t
Slide 16: Agenda
Agenda Global Result Statement Financial Position Statement Financial Indicators & Cash Flows
Slide 17: Financial Indicators
Financial Indicators CAPITAL PROFITABILITY AND RETURN 30-Sep-20 31-Dec-19 LIQUIDITY AND WORKING CAPITAL Efficiency of available capital 30-Sep-20 31-Dec-19 Profit before interest and tax (A) 55.728.249 62.468.452 General liquidity rate Available capital (B) 283.445.872 257.837.329 Current assets 201
Slide 18: Cash Flows
Cash Flows - RON- 30-Sept-2020 31-Dec-2019 Flows from operating activities Profit before tax 55.728.249 62.468.452 Adjustments for: Receivable adjustment 568.622 (4.625.149) Adjustment of inventories (1.805.009) 71.933 Amortisations and provisions 8.160.136 8.095.349 Modification of the real estate
Slide 19: Thank you!
; Thank you!